Enanta Pharmaceuticals shares owned by ALPS Advisors
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by ALPS Advisors
from 13F filings
Historical chart of ALPS Advisors investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by ALPS Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $166k | 16k | 10.36 |
| 2024-03-31 | $261k | 15k | 17.46 |
| 2023-12-31 | $137k | 15k | 9.41 |
| 2023-09-30 | $173k | 16k | 11.17 |
| 2023-06-30 | $331k | 16k | 21.40 |
| 2023-03-31 | $556k | 14k | 40.44 |
| 2022-12-31 | $655k | 14k | 46.52 |
| 2022-09-30 | $585k | 11k | 51.84 |
| 2022-06-30 | $581k | 12k | 47.29 |
| 2022-03-31 | $1.5M | 21k | 71.17 |
| 2021-12-31 | $1.8M | 24k | 74.78 |
| 2021-09-30 | $1.4M | 25k | 56.80 |
| 2021-06-30 | $1.2M | 27k | 44.03 |
| 2021-03-31 | $1.8M | 36k | 49.31 |
| 2020-12-31 | $1.5M | 36k | 42.10 |
| 2020-09-30 | $1.2M | 26k | 45.79 |
| 2020-06-30 | $1.4M | 27k | 50.21 |
| 2020-03-31 | $1.8M | 36k | 51.44 |
| 2019-12-31 | $2.5M | 40k | 61.77 |
| 2019-09-30 | $2.4M | 39k | 60.09 |
| 2019-06-30 | $3.8M | 45k | 84.39 |
| 2019-03-31 | $4.9M | 51k | 95.52 |
| 2018-12-31 | $3.5M | 50k | 70.83 |
| 2018-09-30 | $3.4M | 40k | 85.45 |
| 2018-06-30 | $1.2M | 21k | 58.69 |
| 2018-03-31 | $2.5M | 31k | 80.89 |
| 2017-12-31 | $1.2M | 21k | 58.69 |
| 2017-09-30 | $877k | 19k | 46.78 |
| 2017-06-30 | $618k | 17k | 35.97 |
| 2017-03-31 | $504k | 16k | 30.78 |
| 2016-12-31 | $1.2M | 36k | 33.50 |
| 2016-09-30 | $1.1M | 42k | 26.61 |
| 2016-06-30 | $910k | 41k | 22.05 |
| 2016-03-31 | $1.1M | 37k | 29.38 |
| 2015-12-31 | $1.2M | 37k | 33.01 |
| 2015-09-30 | $15M | 41k | 361.39 |
| 2015-06-30 | $1.5M | 34k | 45.00 |
| 2015-03-31 | $746k | 24k | 30.60 |
| 2014-12-31 | $690k | 14k | 50.83 |
| 2014-09-30 | $590k | 15k | 39.60 |